296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Affiliations

Showing 5 results for affiliation "Genentech, Inc., South San Francisco, CA, USA".

Back to affiliations

Thumbnail for 12-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in Patients With�nAMD�or DMO�From�The�Global, Prospective Observational�VOYAGER�Study

P129

12-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in Patients With�nAMD�or DMO�From�The�Global, Prospective Observational�VOYAGER�Study

Clare Bailey, Steffen Schmitz-Valckenberg, Mariacristina Parravano, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria Chi, Robert Finger, Susumu Ishida, Adrian Koh, Monica Lövestam-Adrian, Jo...

Genentech, Inc., South San Francisco, CA, USA, F. Hoffmann-La Roche Ltd., Basel, Switzerland, Bristol Eye Hospital, University Hospitals Bristol, NHS Foundation Trust, Bristol, UK, John A. Moran Eye Center, Uni...

Poster Presenter: Clare Bailey

Thumbnail for Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

P157

Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

Christine Kiire, Deepali Varma, Sobha Sivaprasad, Ian Pearce, James Talks, Richard Gale, Louise Downey, Gloria Chi, Abigail Darnell, Melanie Dodds, Parul Dayal

Genentech, Inc., South San Francisco, CA, USA, Roche Products Ltd., Welwyn Garden City, UK, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK, South Tyneside and Sunderland NHS Foundation Trust...

Poster Presenter: Christine Kiire

Thumbnail for Two-year Effectiveness, Durability and Safety of Faricimab in Eyes With Diabetic Macular Oedema: Results From the UK FARWIDE-DMO Study

P205

Two-year Effectiveness, Durability and Safety of Faricimab in Eyes With Diabetic Macular Oedema: Results From the UK FARWIDE-DMO Study

Rhianon Reynolds, Christine Kiire, Sobha Sivaprasad, Tunde Peto, Clare Bailey, Louise Downey, Ian Pearce, Gloria Chi, Abigail Darnell, Melanie Dodds, Parul Dayal

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK, Genentech, Inc., South San Francisco, CA, USA, Roche Products Ltd., Welwyn Garden City, UK, Liverpool University Hospitals NHS Fo...

Poster Presenter: Rhianon Reynolds

Thumbnail for Two-Year�Effectiveness, Durability�and Safety of�Faricimab�in Eyes�With�Neovascular�Age Related�Macular�Degeneration: Results�From�the UK FARWIDE-nAMD�Study

P206

Two-Year�Effectiveness, Durability�and Safety of�Faricimab�in Eyes�With�Neovascular�Age Related�Macular�Degeneration: Results�From�the UK FARWIDE-nAMD�Study

Samantha de Silva, Deepali Varma, Gabriella De Salvo, James Talks, Praveen Patel, Richard Gale, Gloria Chi, Abigail Darnell, Melanie Dodds, Parul Dayal

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK, Genentech, Inc., South San Francisco, CA, USA, Roche Products Ltd., Welwyn Garden City, UK, Oxford University Hospitals NHS Found...

Poster Presenter: Samantha De Silva

P278

Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Week 16 Results from the Phase 3 MEERKAT/SANDCAT Trials

Carlos Pavesio, Rahul Khurana, Nisha Acharya, Koh-Hei Sonoda, Christopher Brittain, Sascha Fauser, Deanna Galloway, Zdenka Haskova, Emma Harrell, Marina Mesquida, David Silverman, Laura Stee...

Moorfields Eye Hospital, London, UK, Northern California Retina Vitreous Associates, Mountain View, CA, USA, Francis I. Proctor Foundation and Department of Ophthalmology, University of California, San Francisc...

Poster Presenter: Carlos Pavesio